Longevity & AgingMike Lustgarten Tracks Biological Age and CVD Risk With His Second 2026 Blood Test
Mike Lustgarten, a longevity researcher, shares results from his second blood test of 2026, focusing on biological age via PhenoAge, cardiovascular disease risk using risk-weighted ApoB, and how specific dietary choices correlate with his biomarkers. Rather than relying on a single annual checkup, Lustgarten tracks frequent blood panels to detect trends and make precise dietary adjustments. Key metrics include inflammatory markers, lipid panels, kidney function, and epigenetic aging clocks. His approach demonstrates how self-quantification combined with diet tracking can help individuals identify what moves their health markers in the right direction. This video is part of an ongoing longitudinal self-experiment aimed at optimizing healthspan and slowing biological aging through data-driven lifestyle interventions.
